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Abstract
Background: SNAP25 is an essential SNARE protein for regulated exocytosis in neuronal cells. Differential splicing
of the SNAP25 gene results in the expression of two transcripts, SNAP25a and SNAP25b. These splice variants differ
by only 9 amino acids, and studies of their expression to date have been limited to analysis of the corresponding
mRNAs. Although these studies have been highly informative, it is possible that factors such as differential turnover
of the SNAP25 proteins could complicate interpretations based entirely on mRNA expression profiles.
Results: We report the generation and characterization of antibodies that distinguish between SNAP25a and
SNAP25b isoforms, and their use to investigate the expression profile of these proteins in rat and human brain. In
rat brain, SNAP25b protein expression increased dramatically during post-natal development, whereas the increase
in SNAP25a expression was more modest and variable. The extent of this up-regulation in SNAP25b expression was
similar across cortex, cerebellum and hippocampus. The SNAP25 isoforms also displayed distinct regional
expression patterns, with SNAP25a very weakly expressed in both rat and human cerebellum. Quantitative analysis
revealed that SNAP25b was the dominant isoform in all adult human brain regions examined.
Conclusions: SNAP25a and SNAP25b display distinct developmental and regional expression profiles in rat and
human brain. These differences might reflect distinct functions of these highly conserved isoforms in membrane
fusion pathways in the brain. The antibodies generated and characterized in this study represent important tools
for future analyses of these essential SNARE protein isoforms.
Background
Exocytosis, the fusion of intracellular secretory vesicles
with the plasma membrane, is essential for protein tar-
geting and for secretion of soluble vesicle components
to the extracellular milieu. This pathway occurs consti-
tutively in all cell types but can also be a highly regu-
lated process, such as synaptic vesicle exocytosis in
neurons. The exocytosis of synaptic vesicles is driven by
interactions between the plasma membrane SNARE pro-
teins syntaxin 1 and SNAP25 and the vesicle SNARE
VAMP2 [1-3]. These neuronal SNARE proteins are spe-
cific targets of the potent botulinum and tetanus neuro-
toxins, emphasizing their essential functions in synaptic
vesicle fusion events [4-9]. In contrast to syntaxin 1 and
synaptobrevin, which are transmembrane proteins,
SNAP25 is synthesized as a soluble protein and is
anchored to membranes via the palmitoylation of a cen-
tral cysteine-rich cluster [10,11].
SNAP25 is expressed as alternatively spliced isoforms,
SNAP25a and SNAP25b [12,13]. These splice variants
differ by only 9 out of 206 amino acids, a result of dif-
ferential usage of two alternative exon 5 sequences
(exon 5a/5b). Interestingly, three of the non-conserved
residues occur within the cysteine-rich domain, altering
the configuration of the palmitoylated cysteines. These
differences in the cysteine-rich domains of SNAP25a
and SNAP25b may affect their interaction with palmi-
toyl transferases [14], and the precise intracellular tar-
geting of the proteins [15,16].
Whereas SNAP25a/b expression is restricted to neuro-
nal cells and a small number of cells outside the central
nervous system (adrenal medullary chromaffin cells and
pancreatic beta cells), SNAP23 is expressed ubiquitously
[17,18]. SNAP23 is ~ 60% identical to SNAP25, and has
been proposed to function in both regulated exocytosis
and constitutive membrane fusion events [19-21].
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Elegant electrophysiological studies using adrenal
medullary chromaffin cells from SNAP25 null mouse
embryos revealed that over-expression of either
SNAP25a or SNAP25b rescues exocytosis [22]. Interest-
ingly though, SNAP25b supports more exocytosis than
SNAP25a in this system, clearly showing that the iso-
forms do not have directly interchangeable functions
[22]. Indeed, transgenic mice in which exon 5b is
replaced with an extra copy of exon 5a (leading to the
exclusive expression of the SNAP25a isoform) exhibit
developmental defects, seizures and impairment of
learning [23].
Despite the importance of the SNAP25 splice variants,
there have been no comparative analyses of endogenous
SNAP25a and SNAP25b protein expression; this is
entirely due to a lack of suitable antibodies to distin-
guish between the splice variants. As a result, all charac-
terization of endogenously expressed SNAP25a/b has
been performed at the mRNA level. Interestingly, in
mice, SNAP25a and SNAP25b transcript levels are
broadly similar until around two weeks after birth, fol-
lowing which there is a dramatic up-regulation of
SNAP25b levels [15]. In contrast, levels of SNAP25a
mRNA exhibit at best a marginal increase during post-
natal development in the same samples [15]. A similar
post-natal increase in SNAP25b expression was reported
for rat brain [24]. The mRNA encoding SNAP25a and
SNAP25b also exhibit differences in regional expression,
for example, at P14 SNAP25a was enriched in layer IV
of the cortex, whereas SNAP25b was more abundant in
the outer and inner cortical layers [15]. Whereas
SNAP25b mRNA is the most abundant isoform
expressed in many post-natal brain regions, SNAP25a
mRNA is the major isoform in adrenal and pituitary
glands and in neuroendocrine PC12 cells [15,25].
Analysis of the mRNA expression profiles of SNAP25a
and SNAP25b has provided important information on
the relative expression of these SNAP25 splice variants.
However there is not always a direct correlation
between mRNA levels and protein expression [23]. Here
we describe the generation and characterization of anti-
bodies that can distinguish between SNAP25a and
SNAP25b, and their use to investigate developmental
and regional patterns of expression of the splice variants
in rat and human brain.
Results
Generation and characterization of antibodies that
selectively recognize either SNAP25a or SNAP25b
To study the expression profile of SNAP25a and
SNAP25b proteins, rabbits were immunized with pep-
tides that correspond to non-conserved regions of the
isoforms present within the differentially spliced exon 5
(Figure 1A). These different peptides did not contain
more than four identical contiguous amino acids and
only 10 out of 15 residues were identical (Figure 1A).
IgG fractions were purified from the collected antisera:
IgG #3067 was from rabbits immunized with the
SNAP25a peptide and IgG #3068 was from rabbits
immunized with the SNAP25b peptide.
To test the specificity of the antibodies, lysates were
prepared from HEK293T cells that had been transfected
with EGFP-SNAP25a, EGFP-SNAP25b or EGFP-
SNAP23. IgG 3067 specifically recognized SNAP25a, and
IgG 3068 detected SNAP25b but not SNAP25a (Figure
1B). Figure 1A shows that the sequence of SNAP23 in
the region used for peptide synthesis is very similar to
SNAP25b; consistent with this, the 3068 antibody also
displayed immunoreactivity against SNAP23 (Figure 1B).
To examine whether the 3067 and 3068 antibodies
could distinguish between endogenously expressed
SNAP25a and SNAP25b, lysates were prepared from cere-
bellum samples from wild-type mice and from mice in
which exon 5b is replaced with an additional copy of exon
5a (SNAP25a/a) [23]. As a result of this replacement, these
transgenic mice exclusively express SNAP25a. The 3067
and 3068 antibodies exhibited very high selectivity towards
endogenous SNAP25a and SNAP25b, respectively (Figure
1C). Total SNAP25 and SNAP23 levels were not notice-
ably different between the samples (Figure 1C), and the
massive increase in SNAP25a levels in the SNAP25a/a cer-
ebellum reflects the much higher expression of the
SNAP25b isoform in this brain region of wild-type animals
(see later). The very faint residual band detected by the
3068 antibody in the cerebellum of SNAP25a/a mice is pre-
sumably SNAP23, highlighting the vast excess of
SNAP25b protein compared with SNAP23 in brain sam-
ples. This observation is important as it shows that cross-
reactivity with SNAP23 has a negligible contribution to
overall signal intensity of the 3068 antibody in brain. Col-
lectively, the results displayed in Figure 1 demonstrate the
specificity of the 3067 and 3068 antibodies towards
SNAP25a and SNAP25b respectively, and show that these
antibodies reliably report on the relative expression levels
of the endogenously expressed protein isoforms.
Developmental expression of SNAP25a and SNAP25b in
rat brain
SNAP25 displays a marked increase in expression from
around post-natal week two in mice, and analysis of
mRNA levels demonstrated a specific increase in the
SNAP25b transcript at this stage [15]. However, expres-
sion of SNAP25a/b proteins will be affected by both
transcriptional and post-transcriptional (e.g. protein sta-
bility) effects. Therefore, we examined how SNAP25a/b
protein levels change during post-natal development.
Brain lysates prepared from Sprague Dawley rats at dif-
ferent ages were probed with the 3067 and 3068
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Figure 1 Characterization of 3067 and 3068 antibodies. A) The top schematic (in blue) shows the domain structure of SNAP25; SN1 and SN2
denote the respective SNARE domains. An alignment of the peptide sequences from rat SNAP25a and SNAP25b that were used for antibody
production is also shown. The sequence of rat SNAP23 in the corresponding region is provided for comparison. Numbers indicate the position
of the peptides in relation to the full-length proteins. The shading highlights conserved residues in SNAP25a and SNAP25b. The shading for
SNAP23 highlights amino acids that are identical to those in the corresponding region of SNAP25b. B) HEK293T cells were transfected with
plasmids encoding EGFP-tagged SNAP25a, SNAP25b and SNAP23. Equal volumes of lysates from the transfected cells were probed with
antibodies against SNAP25a (3067), SNAP25b (3068), SNAP23 (Synaptic Systems), and GFP (Roche). C) Cerebellum lysates from wild-type or
SNAP25a/a mice were resolved by SDS-PAGE and transferred to nitrocellulose for immunoblotting analysis using 3067, 3068, pan-SNAP25 and
SNAP23 antibodies. The position of molecular weight markers are shown on the left side of panels B and C.
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Figure 2 Developmental expression patterns of SNAP25a and SNAP25b in rat brain. A) Left panel, Equal amounts of whole brain lysates
prepared from rats at different developmental stages (supplied by Zyagen Inc.) were resolved by SDS-PAGE and transferred to nitrocellulose for
immunoblotting analysis using 3067, 3068, panSNAP25, SNAP23 and actin antibodies. Right panel shows the mean (+/-SEM) fold increase in
expression levels of SNAP23, SNAP25a and SNAP25b between a late embryonic stage (E18-E20) and P30-32 (n = 3). The fold increase in
SNAP25b expression was significantly greater than that of either SNAP25a (P < 0.05) or SNAP23 (p < 0.02), analysed using a one-way ANOVA. B)
Equal amounts of brain lysates from gender-determined E20 litter mates were resolved on SDS-PAGE gels beside an aliquot of P32 brain lysate
and analyzed as in panel A. C) Lysates from the hippocampus, cerebellum and cortex were prepared from pooled samples collected from 3
animals at P2 or P20. Samples were analyzed as in Panel A. Position of molecular weight standards are shown on the left of all panels.
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antibodies. SNAP25b exhibited a dramatic up-regulation
in expression beginning at around post-natal week two
(Figure 2A); similar increases in SNAP25b expression
were observed in every set of samples that we tested.
SNAP25a also exhibited a developmental increase but
this was more modest and variable than SNAP25b
(Figure 2A). Expression levels of SNAP23 were relatively
constant throughout development (Figure 2A). For
quantification purposes, we compared mean values of
the fold increase in brain expression levels of the
SNAP25/23 isoforms between a late embryonic stage
(E18-E20) and ~ 1 month after birth (P30-P32). The
graph in Figure 2A highlights the robust increase in
SNAP25b levels during this period compared with
SNAP25a and SNAP23. No gender-specific differences
in SNAP25a/b expression levels were apparent at E20
(Figure 2B).
We next examined if the developmental increase in
SNAP25b levels was similar in different brain regions.
The hippocampus, cerebellum and cortex were collected
from rats at P2 and P20 (3 animals per age) and lysed.
Figure 2C reveals that SNAP25b expression increased
between P2 and P20 to a similar extent in each brain
region tested.
Regional expression of SNAP25a and SNAP25b in rat
brain
To compare the regional expression levels of SNAP25a
and SNAP25b in brain, samples of hippocampus,
hypothalamus, thalamus, cerebellum and cortex from
~10 week-old rats were analyzed by immunoblotting.
SNAP25a displayed highest levels (per μg of total pro-
tein) in cortex and hypothalamus (Figure 3), whereas
SNAP25b had the highest immunoreactivity in cortex
and cerebellum lysates. A marked difference in regional
expression levels between the SNAP25 isoforms was
detected in cerebellum: SNAP25b expression was high-
est in this brain region, whereas SNAP25a expression
was lowest (Figure 3). Probing the brain region lysates
with a panSNAP25 antibody revealed that total SNAP25
expression levels mirrored those of SNAP25b (Figure 3,
third panel), consistent with the idea that SNAP25b is
the major SNAP25 isoform expressed in adult brain.
Regional expression and semi-quantitative comparison of
SNAP25a, SNAP25b, and SNAP23 in human brain
Having characterized regional expression patterns of
SNAP25a and SNAP25b in rat brain, we next examined
expression in post-mortem samples of human brain. For
this, lysates of cortex, hippocampus, cerebellum and tha-
lamus were prepared from 6 post-mortem brains. Equal
amounts of the individual lysates from each brain region
were then pooled and resolved on SDS-PAGE gels
alongside a dilution series of HEK293T lysates from
cells transfected with EGFP-SNAP25a, EGFP-SNAP25b
or EGFP-SNAP23 (Figure 4A). Densitometry was then
used to estimate the relative expression levels of
SNAP25a, SNAP25b and SNAP23 in the different brain
regions by comparison with the EGFP-tagged standards
(Figure 4B). This semi-quantitative analysis revealed that
expression of SNAP25b was highest and SNAP23
expression lowest in every brain region examined. The
expression pattern of SNAP25a in human brain was
grossly similar to that observed in rat brain, with this
isoform highest in cortex and only weakly expressed in
cerebellum.
Discussion
The generation of antibodies that distinguish between
SNAP25 splice variants is an important development
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Figure 3 Regional expression of SNAP25a and SNAP25b in rat
brain. Lysates from various brain regions (supplied by Zyagen; 3
animals/sample; ~ 10 week old) were resolved by SDS-PAGE and
transferred to nitrocellulose for immunoblotting analysis using
antibodies against SNAP25a (3067), SNAP25b (3068), panSNAP25,
SNAP23 or actin. Position of molecular weight markers are shown
on the left side of all blots.
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Figure 4 Semi-quantitative comparison of SNAP25 isoform expression levels in human brain. A) Lysates prepared from post-mortem
brain samples (pooled from 6 individual patients) were resolved by SDS-PAGE alongside various dilutions of HEK293T lysates from cells
transfected with EGFP-SNAP25a, EGFP-SNAP25b or EGFP-SNAP23. Gels were transferred to nitrocellulose and immunoblotted using antibodies
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comparison of band intensities to those of the respective EGFP-tagged proteins. Highest expression levels were for SNAP25b in cortex and this
was given an arbitrary value of 1, with all other values expressed as a fraction of this.
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that will significantly advance the study of these protein
isoforms. RNA analysis provides a measure of relative
protein expression levels but this can be complicated by
differential protein turnover and stability. Antibodies
also offer scope to study the intracellular localization of
the endogenously expressed proteins, and to determine
if the distinct cysteine-rich domains of SNAP25a/b med-
iate different intracellular sorting patterns; these ana-
lyses are ongoing in our laboratory. Cross-reactivity of
the SNAP25b antibody (3068) with SNAP23 was una-
voidable. However, Figure 1C and Figure 4 demonstrate
that SNAP25b is expressed at much higher levels than
SNAP23 in brain, and that the contribution of SNAP23
to signal intensity with the 3068 antibody is negligible.
However, cross-reactivity is likely to be more of an issue
when using the 3068 antibody on samples other than
brain, or in brain areas where SNAP25b is weakly
expressed.
Previous work had shown that SNAP25b mRNA is
selectively up-regulated during post-natal development
[15,24]. Our study is in broad agreement with these
findings. However in some experiments we did also
detect a marked increase in SNAP25a expression; we
currently do not know the reason for this variability.
Nevertheless, these observations suggest that mRNA
analyses may not provide a complete picture of
SNAP25a/b expression levels and indicates that the sta-
bility of SNAP25a protein may change during post-natal
development. The increased post-natal expression of
SNAP25b was similar in hippocampus, cerebellum and
cortex, implying that changes in expression of this iso-
form are largely occurring at a global level.
SNAP25a and SNAP25b displayed differential patterns
of expression in gross brain regions. In rat brain, a
marked difference was found in cerebellum, where
SNAP25b was highly expressed and SNAP25a was only
present at low levels. The weak expression of SNAP25a
in cerebellum was also observed in post-mortem sam-
ples from human brain. It is possible that SNAP25b is
the more evolutionarily-ancient of the two SNAP25 iso-
forms given that SNAP25b shares higher sequence iden-
tity with SNAP23 (Figure 1A). These new antibodies
offer scope to extend upon these observations, for
example, by analyzing how the isoforms are distributed
in more defined sub-regions of the brain or in specific
neuronal populations.
The increased level of exocytosis supported by
SNAP25b in mouse embryonic chromaffin cells was
shown to be attributable to splicing differences that
occur upstream of the palmitoylated cysteines
[22,26,27]. These results might suggest that differential
palmitoylation of SNAP25a and SNAP25b does not
impact on the functionality of the isoforms. However
functional outcomes attributable to differences within
the palmitoylated cysteine-rich domains of SNAP25a/b
will probably arise via changes in membrane interaction
and/or lateral organization in the membrane [16,28,29].
These parameters are likely to be saturated by the high
level over-expression (approximately 20-fold) achieved
in these studies. Thus, there is some merit in studying
the expression and localization of SNAP25a/b at high
resolution. In particular, the use of specific antibodies
against these proteins will be important to analyse pat-
terning of the endogenous proteins and thus without
any confounding effects of over-expression or fluores-
cent tags. Similarly, it will be interesting in the future to
assess whether functional effects related to the different
cysteine-rich domains of these SNAP25 isoforms are
apparent when the proteins are expressed at endogenous
levels.
At a similar time when this work was submitted for
publication, a paper was published by the Takahashi
group also describing the production of isoform-specific
antibodies against the SNAP25 family and their use to
analyse expression of the proteins in mouse brain [30].
Similar to our study, this study reported relatively low
expression levels of SNAP25a in cerebellum, and that
SNAP25b is the major isoform expressed in brain (~10-
fold higher than SNAP25a in hippocampus).
Conclusions
We have shown that SNAP25a and SNAP25b proteins
display distinct regional and developmental profiles in rat
and human brain. This analysis will be helpful in further
delineating how the function of these isoforms overlaps
and/or is distinct. The antibodies generated in the study
will serve as useful tools for future work in this area.
Methods
Chemicals
Lipofectamine 2000 was purchased from Invitrogen
(Paisley, UK). COMPLETE Protease inhibitor cocktail
tablets were from Roche (Buckinghamshire, UK). NP40,
acrylamide and all other reagents were of an analytical
grade from Sigma (Poole, UK).
Antibodies
Peptide synthesis and antibody production was per-
formed by Eurogentec; the sequences of peptides used
for immunization are shown in Figure 1A. IgG fractions
from recovered antisera were purified on protein A
agarose and dialyzed against phosphate buffered saline
(PBS). Purified IgGs were aliquoted and stored at -80°C.
For immunoblotting, the purified IgGs were used at a
final concentration of 1 μg/ml in PBS supplemented
with 0.05% Tween-20. Antibody incubations were per-
formed as standard for 60 min at room temperature
with gentle shaking.
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Rabbit SNAP23 antibody and mouse monoclonal
SNAP25 antibody were from Synaptic Systems (Gottingen,
Germany). Monoclonal actin antibody was purchased
from Abcam (Cambridge, UK). Monoclonal anti-GFP
(JL8) was from Roche (Buckinghamshire, UK).
Plasmids
Plasmids encoding SNAP25a, SNAP25b and SNAP23
tagged N-terminally with EGFP have been previously
described [14].
Cell culture and transfection
HEK293T cells were obtained from ATCC and cultured
in DMEM with 10% fetal bovine serum in a humidified
atmosphere containing 5% CO2. Cells were transfected
using Lipofectamine 2000 (Invitrogen, Paisley, UK)
according to the manufacturer’s instructions.
Animals
Unless otherwise stated, all samples used were collected
from in-house bred Sprague Dawley rats, following
internationally recognise guidelines. The rat brain region
lysates that were analyzed in Figure 3 were obtained
from Zyagen (San Diego, USA). These samples represent
pooled fractions from at least 3 different Sprague Daw-
ley rats, approximate age 10 weeks old. Zyagen also sup-
plied the developmental samples that were analyzed in
Figure 2A. These samples are whole brain lysates from
one Sprague Dawley rat of each age. The cerebellum
samples from wild-type and SNAP25a/a mice were
kindly supplied by Dr Christina Bark (Karolinska Insti-
tute, Sweden).
Preparation of tissue lysates and SDS-PAGE
Brain lysates were prepared by homogenization of sam-
ples in ice-cold buffer A [20 mM HEPES, 1 mM MgCl2,
250 mM sucrose, 2 mM EDTA, 1% NP-40 and protease
inhibitor cocktail (Roche), pH 7.4] using a Dounce homo-
genizer. Insoluble material was removed by centrifuga-
tion 4,000 xg for 2 min. The protein content of recovered
lysates was determined, and equal amounts of the various
lysates were resolved by SDS-PAGE and transferred to
nitrocellulose for immunoblotting analysis.
Human post-mortem brain samples
Frozen samples from histologically characterised normal
brain tissues authorised for ethically approved scientific
research (Lothian Research Ethical Committee; ref.
2003/8/37) were gratefully provided by Robert Walker
at the Medical Research Council Sudden Death Brain
and Tissue Bank, University of Edinburgh [26], and stu-
died in collaboration with Douglas Blackwood and
Donald McIntyre, Division of Psychiatry, University of
Edinburgh (ethical approval reference MREC/99/0/12).
Tissue samples from 6 post-mortem brains were
dissected from the cortex, hippocampus, cerebellum and
thalamus. Lysates were prepared as described for the rat
brain samples.
Abbreviations
SNAP25: synaptosomal-associated protein of 25 kDa; SNAP23: SNAP25
homologue of 23 kDa.
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